C12N 2501/999
Small molecules not provided for elsewhere
C12N2501/999 (Small molecules not provided for elsewhere) appears on 1,085 US grants and 2,323 published applications in this corpus.
Search patents in C12N- Granted patents
- 1,085
- Published applications
- 2,323
- Assignees
- 1,017
- Inventors
- 4,390
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 2 | 0 |
| 2000 | 4 | 0 |
| 2001 | 2 | 5 |
| 2002 | 4 | 19 |
| 2003 | 10 | 20 |
| 2004 | 3 | 13 |
| 2005 | 4 | 28 |
| 2006 | 7 | 11 |
| 2007 | 7 | 17 |
| 2008 | 8 | 22 |
| 2009 | 9 | 37 |
| 2010 | 13 | 36 |
| 2011 | 10 | 35 |
| 2012 | 20 | 40 |
| 2013 | 12 | 54 |
| 2014 | 22 | 67 |
| 2015 | 33 | 102 |
| 2016 | 52 | 134 |
| 2017 | 48 | 143 |
| 2018 | 89 | 155 |
| 2019 | 94 | 204 |
| 2020 | 86 | 229 |
| 2021 | 92 | 216 |
| 2022 | 84 | 127 |
| 2023 | 95 | 161 |
| 2024 | 104 | 170 |
| 2025 | 93 | 174 |
| 2026 | 67 | 104 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for producing cell sheet6 Oct 2026US 12,753,390 B2Kaneka Corporation
- Composition for enhancing reprogramming efficiency from somatic cell to induced pluripotent stem cell, comprising mTOR activator, and method for enhancing reprogramming efficiency by using same6 Oct 2026US 12,753,394 B2Korea University Research and Business Foundation
- Haematopoietic stem/progenitor cells29 Sep 2026US 12,747,424 B2Murdoch Childrens Research Institute
- Ex vivo proliferation of epithelial cells29 Sep 2026US 12,747,425 B2Propagenix Inc.
- Methods of differentiating neural cells and related compositions and methods of use15 Sep 2026US 12,734,196 B2Aspen Neuroscience, Inc.
- Novel phosphoantigen prodrug compound and use thereof8 Oct 2026US 2026/0306541 A1
- Composition for inducing dendritic cell differentiation, comprising metal-organic framework, and use thereof8 Oct 2026US 2026/0308523 A1Mediark Inc.
- Cryopreserved endocrine cells that express chromogranin a1 Oct 2026US 2026/0294981 A1ViaCyte, Inc.
- Modulators of protein secretion1 Oct 2026US 2026/0297508 A1Institut National de la Sante et de la Recherche Medicale
- Radial Glia and Astrocyte Differentiation from Human Pluripotent Stem Cells24 Sep 2026US 2026/0286296 A1The United States of America, as represented by the Secretary, Dept. of Heath and Human Services
Most cited
By later US patents
- Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair304US 6,429,013 B1Artecel Science, Inc. · 2002
- Maturation of dendritic cells with immune response modifying compounds206US 6,558,951 B13M Innovative Properties Company · 2003
- Methods of producing pancreatic hormones165US 7,534,608 B2Cythera, Inc. · 2009
- Conditioned media for propagating human pluripotent stem cells145US 6,642,048 B2Geron Corporation · 2003
- Culturing human embryonic stem cells in medium containing pipecholic acid and gamma amino butyric acid139US 7,442,548 B2Wisconsin Alumni Research Foundation · 2008